Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers, Cancers et Préventions, Normandie Université, Université de Caen Normandie, Inserm, Institut Gustave Roussy, Clinica Universidad de Navarra, University of Oklahoma Health Sciences Center, Memorial Sloan Kettering Cancer Center, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1